S&P 500   5,085.47 (-0.03%)
DOW   39,189.88 (+0.31%)
QQQ   436.83 (-0.28%)
AAPL   182.96 (-0.76%)
MSFT   411.11 (-0.13%)
META   485.87 (-0.05%)
GOOGL   143.76 (-0.23%)
AMZN   174.35 (-0.13%)
TSLA   195.08 (-1.18%)
NVDA   785.72 (+0.04%)
NIO   5.42 (-7.35%)
AMD   176.05 (-3.19%)
BABA   76.09 (-0.04%)
T   16.83 (+1.45%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   152.92 (+0.82%)
DIS   106.50 (-1.06%)
AMC   4.34 (-1.81%)
PFE   28.04 (+1.78%)
PYPL   59.01 (+1.13%)
XOM   103.73 (-0.98%)
S&P 500   5,085.47 (-0.03%)
DOW   39,189.88 (+0.31%)
QQQ   436.83 (-0.28%)
AAPL   182.96 (-0.76%)
MSFT   411.11 (-0.13%)
META   485.87 (-0.05%)
GOOGL   143.76 (-0.23%)
AMZN   174.35 (-0.13%)
TSLA   195.08 (-1.18%)
NVDA   785.72 (+0.04%)
NIO   5.42 (-7.35%)
AMD   176.05 (-3.19%)
BABA   76.09 (-0.04%)
T   16.83 (+1.45%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   152.92 (+0.82%)
DIS   106.50 (-1.06%)
AMC   4.34 (-1.81%)
PFE   28.04 (+1.78%)
PYPL   59.01 (+1.13%)
XOM   103.73 (-0.98%)
S&P 500   5,085.47 (-0.03%)
DOW   39,189.88 (+0.31%)
QQQ   436.83 (-0.28%)
AAPL   182.96 (-0.76%)
MSFT   411.11 (-0.13%)
META   485.87 (-0.05%)
GOOGL   143.76 (-0.23%)
AMZN   174.35 (-0.13%)
TSLA   195.08 (-1.18%)
NVDA   785.72 (+0.04%)
NIO   5.42 (-7.35%)
AMD   176.05 (-3.19%)
BABA   76.09 (-0.04%)
T   16.83 (+1.45%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   152.92 (+0.82%)
DIS   106.50 (-1.06%)
AMC   4.34 (-1.81%)
PFE   28.04 (+1.78%)
PYPL   59.01 (+1.13%)
XOM   103.73 (-0.98%)
S&P 500   5,085.47 (-0.03%)
DOW   39,189.88 (+0.31%)
QQQ   436.83 (-0.28%)
AAPL   182.96 (-0.76%)
MSFT   411.11 (-0.13%)
META   485.87 (-0.05%)
GOOGL   143.76 (-0.23%)
AMZN   174.35 (-0.13%)
TSLA   195.08 (-1.18%)
NVDA   785.72 (+0.04%)
NIO   5.42 (-7.35%)
AMD   176.05 (-3.19%)
BABA   76.09 (-0.04%)
T   16.83 (+1.45%)
F   12.20 (+0.66%)
MU   85.23 (-0.79%)
CGC   3.23 (-4.15%)
GE   152.92 (+0.82%)
DIS   106.50 (-1.06%)
AMC   4.34 (-1.81%)
PFE   28.04 (+1.78%)
PYPL   59.01 (+1.13%)
XOM   103.73 (-0.98%)
NASDAQ:ACB

Aurora Cannabis (ACB) Stock Price, News & Analysis

$3.22
-0.02 (-0.62%)
(As of 11:04 AM ET)
Today's Range
$3.12
$3.30
50-Day Range
$3.24
$5.00
52-Week Range
$3.12
$11.50
Volume
530,927 shs
Average Volume
700,795 shs
Market Capitalization
$175.62 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

Aurora Cannabis MarketRank™ Stock Analysis

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Bearish
66.34% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.12mentions of Aurora Cannabis in the last 14 days
Based on 20 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
Growing
From ($0.80) to ($0.35) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

0.22 out of 5 stars

Medical Sector

907th out of 935 stocks

Medicinals & Botanicals Industry

10th out of 10 stocks


ACB stock logo

About Aurora Cannabis Stock (NASDAQ:ACB)

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada. It is also involved in the distribution of wholesale medical cannabis in the European Union (EU); distribution of wholesale medical cannabis in various international markets, including Australia, the Caribbean, South America, and Israel; supply of propagated vegetables and ornamental plants in North America; and distribution and sale of hemp-derived cannabidiol (CBD) products. In addition, the company cultivates and sells dried cannabis, cannabis oils, capsules, edible cannabis, cannabis extracts, and soft gels, which are ingested in various ways, including smoking, vaporizing, and consumption in the form of oil, capsules, edibles, and extracts; and provides dried flowers, vapes, dried milled strains, strain-specific extracts, strain specific cannabis oils, and concentrates. Further, it offers recreational cannabis products, such as flowers, vapes, ingestibles, concentrates, extracts, and CBD products; and patient counseling and outreach services. The company's adult-use brand portfolio includes Aurora Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard, as well as CBD brands, Reliva and KG7; and medical cannabis brands include MedReleaf, CanniMed, Aurora, Whistler Medical Marijuana Co, Pedanios, Bidiol, and CraftPlant. Aurora Cannabis Inc. is headquartered in Edmonton, Canada.

ACB Stock Price History

ACB Stock News Headlines

Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
Aurora Cannabis CFO Glen Ibbott Steps Down
Americans Now Favor Gold Over Stocks as an Investment Vehicle
Americans now consider gold a better long-term investment than stocks for the first time since 2013. But physical gold requires storage and insurance, and gold mining stocks come with significant risks. Fortunately, investors have found a little-known way to benefit from gold that avoids many of these challenges.
ACB Feb 2024 1.000 put
ACB Mar 2024 1.000 put
A Preview Of Aurora Cannabis's Earnings
Jefferies Keeps Their Hold Rating on Aurora Cannabis (ACB)
Closing Bell: Aurora Cannabis Inc flat on Friday (ACB)
See More Headlines
Receive ACB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Aurora Cannabis and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/12/2021
Today
2/23/2024
Fiscal Year End
3/31/2024
Next Earnings (Estimated)
6/12/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Medicinals & botanicals
Sub-Industry
N/A
Current Symbol
NASDAQ:ACB
Fax
N/A
Employees
1,338
Year Founded
2006

Profitability

Net Income
$-799,220,000.00
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$211.59 million
Book Value
$7.52 per share

Miscellaneous

Free Float
54,534,000
Market Cap
$176.71 million
Optionable
Optionable
Beta
2.38

Social Links

The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Key Executives

  • Mr. Miguel Martin (Age 51)
    CEO & Director
    Comp: $1.5M
  • Mr. Glen Ibbott
    Chief Financial Officer
  • Mr. Alex Miller
    Executive Vice President of Operations & Supply Chain
  • Ms. Lori Schick
    Executive Vice President of Human Resources
  • Mr. Andre Jerome
    Executive Vice President of Global Business Development
  • Ananth Krishnan
    Vice President of Capital Markets & Investor Relations
  • Ms. Nathalie Clark
    Executive VP, General Counsel & Corporate Secretary
  • Michelle Lefler
    Vice President of Communications & Public Relations
  • Dr. Jonathan Page Ph.D. (Age 55)
    Senior Science Advisor
  • Mr. Rick Savone
    Senior Vice President of Global Government Relations














ACB Stock Analysis - Frequently Asked Questions

Should I buy or sell Aurora Cannabis stock right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Aurora Cannabis in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" ACB shares.
View ACB analyst ratings
or view top-rated stocks.

How have ACB shares performed in 2024?

Aurora Cannabis' stock was trading at $4.7620 on January 1st, 2024. Since then, ACB stock has decreased by 32.0% and is now trading at $3.24.
View the best growth stocks for 2024 here
.

When is Aurora Cannabis' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, June 12th 2024.
View our ACB earnings forecast
.

How were Aurora Cannabis' earnings last quarter?

Aurora Cannabis Inc. (NASDAQ:ACB) announced its earnings results on Wednesday, May, 12th. The company reported ($8.20) earnings per share for the quarter, missing analysts' consensus estimates of ($1.70) by $6.50. The business earned $43.56 million during the quarter, compared to analysts' expectations of $55.17 million. Aurora Cannabis had a negative trailing twelve-month return on equity of 23.27% and a negative net margin of 48.82%.

When did Aurora Cannabis' stock split?

Aurora Cannabis's stock reverse split on Tuesday, February 20th 2024. The 1-10 reverse split was announced on Tuesday, February 20th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Tuesday, February 20th 2024. An investor that had 100 shares of stock prior to the reverse split would have 10 shares after the split.

Who are Aurora Cannabis' major shareholders?

Aurora Cannabis' stock is owned by a variety of institutional and retail investors. Top institutional investors include Mirae Asset Global Investments Co. Ltd. (0.56%), Citadel Advisors LLC (0.00%), TD Asset Management Inc (0.09%), Goldman Sachs Group Inc. (0.06%), Mackenzie Financial Corp (0.04%) and Vontobel Holding Ltd. (0.02%).

How do I buy shares of Aurora Cannabis?

Shares of ACB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

Does Aurora Cannabis have any subsidiaries?
The following companies are subsidiares of Aurora Cannabis: 1769474 Alberta Ltd., 2105657 Alberta Inc., ACB Captive Insurance Company Inc., Anandia Labs Inc, Aurora Cannabis Enterprises Inc., Aurora Deutschland GmbH, Aurora Nordic Cannabis A/S, CanniMed Therapeutics Inc., CanvasRx Holdings, ICC Labs Inc., Larssen Ltd, MedReleaf Corp., Pedanios, Peloton Pharmaceuticals Inc., Reliva LLC, Reliva LLC, Whistler Medical Marijuana Corporation, and Whistler Medical Marijuana Corporation.
Read More
This page (NASDAQ:ACB) was last updated on 2/23/2024 by MarketBeat.com Staff